WuXi Oncology and Immuno-Oncology Services
Integrated Oncology and Immuno-oncology Platform to Enable Translational Science from Drug Discovery to Clinical Biomarker
Oncology Services
- CRISPR/Cas9 Gene Editing
- In Vitro Assay and HTS
- Tumor models
- Tumor Cell Panel and Screening
- Immunology and Immuno-oncology Platform
- Clinical Biomarker
Immunology Services
- Ligand-receptor binding assays
- Cellular functional assays
- Assays for innate immunity pathways: macrophage, MDSC, NK, DC, mast cell
- Adaptive immunity: T, B cell
- 40+ established autoimmune and inflammation disease models
Rare Disease Services | Large Animal Services
Oncology-Immunology-Services
Related Content
WuXi AppTec provides integrated and cost-effective services for: Polyclonal and monoclonal antibodies Anti-drug antibodies (ADA), host cell protein (HCP) antibodies,...
VIEW RESOURCEReview of SITC 2023 Annual Meeting The 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) was held...
VIEW RESOURCE